These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9490681)

  • 1. Tissue factor regulates plasminogen binding and activation.
    Fan Z; Larson PJ; Bognacki J; Raghunath PN; Tomaszewski JE; Kuo A; Canziani G; Chaiken I; Cines DB; Higazi AA
    Blood; 1998 Mar; 91(6):1987-98. PubMed ID: 9490681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
    Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
    Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
    Barnathan ES; Kuo A; Rosenfeld L; Karikó K; Leski M; Robbiati F; Nolli ML; Henkin J; Cines DB
    J Biol Chem; 1990 Feb; 265(5):2865-72. PubMed ID: 2154462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfaces.
    Anglés-Cano E
    Chem Phys Lipids; 1994 Jan; 67-68():353-62. PubMed ID: 8187235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
    Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
    Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR; De Cock F; Collen D
    Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.
    Lin LF; Houng A; Reed GL
    Biochemistry; 2000 Apr; 39(16):4740-5. PubMed ID: 10769130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion protein stimulates tissue-type plasminogen activator-mediated plasmin generation via a lysine-binding site on kringle 2.
    Epple G; Schleuning WD; Kettelgerdes G; Kottgen E; Gessner R; Praus M
    J Thromb Haemost; 2004 Jun; 2(6):962-8. PubMed ID: 15140132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells.
    Kim KS; Hong YK; Joe YA; Lee Y; Shin JY; Park HE; Lee IH; Lee SY; Kang DK; Chang SI; Chung SI
    J Biol Chem; 2003 Mar; 278(13):11449-56. PubMed ID: 12529357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator.
    Silva MM; Thelwell C; Williams SC; Longstaff C
    J Thromb Haemost; 2012 Nov; 10(11):2354-60. PubMed ID: 22974122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells.
    Gonzalez-Gronow M; Gawdi G; Pizzo SV
    Blood; 2002 Jun; 99(12):4562-7. PubMed ID: 12036889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L; Lijnen HR; Collen D; Holmes WE
    J Biol Chem; 1987 Aug; 262(22):10855-62. PubMed ID: 2956260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation.
    Sun Z; Zhang PX; Wang P; Gurewich V; Shen HY; Liu JN
    Thromb Res; 2002 Apr; 106(2):105-11. PubMed ID: 12182908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen binding properties of macrophage inflammatory protein (MIP)-2alpha.
    Arza B; Félez J; Fábregas P; Laroche Y; Collen D; Lijnen HR
    Thromb Haemost; 2000 Jul; 84(1):71-7. PubMed ID: 10928473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
    Suenson E; Lützen O; Thorsen S
    Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of kringle-integrin interaction in plasmin and uPA actions (a hypothesis).
    Takada Y
    J Biomed Biotechnol; 2012; 2012():136302. PubMed ID: 23125522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis.
    Mukhina S; Stepanova V; Traktouev D; Poliakov A; Beabealashvilly R; Gursky Y; Minashkin M; Shevelev A; Tkachuk V
    J Biol Chem; 2000 Jun; 275(22):16450-8. PubMed ID: 10749881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.